• We are a biotech company in
    infectious diseases with a
    first marketed product.

  • Dedicated to innovation in
    vaccine research & development.

  • Valneva covers the full
    value chain from bench
    to market.

Welcome to Valneva

Joining forces to create a European biotech leader in vaccines


— March 26, 2015

Valneva Announces Approval of an EB66®-based Prototype Influenza Vaccine in Japan
Read more

— Stock information



—News, Mar.17, 2015

Signing of an exclusive license agreement on EB66® Cell Line in China

 Read more

— Financial calendar

March 20, 2015

Valneva published its FY 2014 financial results
Download Annual Results Report
Download Financial Statements


All dates     


– Upcoming conferences and fairs

May 24 - 28, 2015
CISTM14 – 14th conference of the International Society of Travel Medicine
Québec City, Canada

June 15 - 18, 2015
Bio International Convention
Philadelphia, United States

Meet our Business Development team

European biotech company with worldwide presence.

Please update your browser...